Reminds me of the groundbreaking CF drug that a university developed and a drug company did trials and wanted to charge $700k a year for it.

As for drug company practices they moved testing offshore to reduce exposure to legal claims and sent production to India and China to reduce production costs by 18 cents per 1000 pills. Oddly given that the offshore producers have a penchant to cheat the quality control systems, approving defective batches, you would think that the increase risk to insurers would cost these drug pushers more than the production savings. This brings up the point as to why does our government NOT require the labelling of all prescription bottles with the country of origin in which the drug was manufactured. It is not even shown on the pharmacist's master bottle.